Innovative therapeutics

sidebar_clinical_trials_achondroplasia

Roadmap to a New Therapy

Roadmap to a new therapy

Click here to open the full-size pdf.

Clinical Trial

Study 111-901: A Multicenter, Multinational Clinical Assessment Study for Pediatric Patients with Achondroplasia
Read more »

Clinical Trial

Study 111-206: A Phase 2 Randomized, Double-Blind, Placebo-Controlled Clinical Trial to Evaluate the Safety and Efficacy of BMN 111 in Infants and Young Children With Achondroplasia, Age 0 to < 60 Months
Read more »

Clinical Trial

Study 111-301: A Phase 3 Randomized, Double-Blind, Placebo-Controlled, Multicenter Study to Evaluate the Efficacy and Safety of BMN 111 in Children with Achondroplasia
Read more »

Clinical Trial

Study 111-202: A Phase 2 Study of BMN 111 to Evaluate Safety, Tolerability, and Efficacy in Children With Achondroplasia (ACH)
Read more »

Clinical Trial

Study 111-101: Phase 1, two-part, double-blind, placebo-controlled study to evaluate safety, tolerability, and pharmacokinetics of single and multiple doses of BMN 111 administered to healthy adult volunteers
Read more »

Clinical Trial

Study 111-205: A Phase 2 Study to Evaluate the Long-Term Safety, Tolerability, and Efficacy of BMN 111 in Children With Achondroplasia
Read more »

Top